Spinal muscular atrophy
(Redirected from Spinal muscular atrophy type 1)
Spinal muscular atrophy (SMA) constitutes a collection of neuromuscular disorders, hallmarked by the degeneration of motor neurons and ensuing progressive muscle wasting. This condition is a notable genetic cause of mortality in infants, though the onset and severity of symptoms can considerably vary between different types of SMA[1].
Classification and Symptoms[edit | edit source]
SMA can manifest at different stages of life, from infancy to adulthood, and its types are primarily distinguished by their onset and severity. All types, however, lead to progressive muscle weakness, typically affecting the arm, leg, and respiratory muscles initially. Additional complications can include difficulty swallowing, scoliosis, and joint contractures. The observable muscle twitching is often a key symptom associated with this disorder[2].
Genetic Basis[edit | edit source]
The genetic basis of SMA resides in a defect in the SMN1 gene, which encodes for survival motor neuron (SMN) protein, essential for the survival of motor neurons. The disorder is inherited in an autosomal recessive manner, meaning both copies of the gene in each cell must have mutations for the disease to manifest. The absence of functional SMN protein leads to the loss of motor neurons, thereby inhibiting the transmission of signals from the brain to the skeletal muscles[3].
Diagnosis[edit | edit source]
Diagnosis of SMA typically begins with a thorough clinical evaluation of the symptoms, followed by confirmatory genetic testing to identify mutations in the SMN1 gene[4].
Treatment and Management[edit | edit source]
The management of SMA involves a multidisciplinary approach that includes physical therapy, nutritional support, and in severe cases, mechanical ventilation. Recently, new therapeutic approaches have emerged. One such treatment, nusinersen, is an antisense oligonucleotide injected into the spinal fluid, which has shown to slow the disease progression and enhance muscle function. Moreover, a gene therapy named onasemnogene abeparvovec has received approval in the US for treating children under 24 months[5].
Prognosis[edit | edit source]
Prognosis for individuals with SMA is highly dependent on the type of SMA. Some forms of the disease may reduce life expectancy to a few months, while others lead to mild muscle weakness but do not significantly affect life expectancy.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD